Phosphate esters in myotonic human muscle.

نویسندگان

  • P C CALDWELL
  • T A PRANKERD
چکیده

Myotonia congenita is a disorder of the relaxation of skeletal muscle in man. The disease is not accompanied by muscular wasting, and is analogous to a disorder in goats (Kolb, 1938; Brown and Harvey, 1939). The affected muscles both of man and goat show similar abnormalities when examined by histological and electromyographic methods. Myotonia becomes apparent during activity after a period of rest. Relaxation is delayed for up to a minute after the first voluntary contraction. With successive contractions the period of myotonic contraction decreases until the muscle eventually behaves like normal muscle. Electromyographic investigations have suggested that both disorders are due primarily to an abnormally high excitability of the muscle membranes, but it is possible that other factors are operative. Current theories of muscular contraction (Baldwin, 1952) assign an important role to phosphate esters. The patient who is to be described willingly consented to biopsy of small samples of affected muscle to see if they showed abnormalities in the distribution of these esters and thus possibly throw further light on the nature of the disease.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Calixmexitil: Calixarene-based Cluster of Mexiletine with Amplified Anti-myotonic Activity as A Novel Use-dependent Sodium Channel Blocker

Mexiletine as the first choice drug in myotonia treatment is a chiral sodium channel blocker clinically used in its racemic form. The phenolic structure of this drug, prompted us to design its novel calix[4]arene-based cluster in a chalice-shaped structure. Therefore, the present study reports the synthesis and in-vitro anti-myotonic activity of the chalice-shaped cluster of mexiletine...

متن کامل

Calixmexitil: Calixarene-based Cluster of Mexiletine with Amplified Anti-myotonic Activity as A Novel Use-dependent Sodium Channel Blocker

Mexiletine as the first choice drug in myotonia treatment is a chiral sodium channel blocker clinically used in its racemic form. The phenolic structure of this drug, prompted us to design its novel calix[4]arene-based cluster in a chalice-shaped structure. Therefore, the present study reports the synthesis and in-vitro anti-myotonic activity of the chalice-shaped cluster of mexiletine...

متن کامل

Skeletal muscle metabolism in myotonic dystrophy A 31P magnetic resonance spectroscopy study.

We have used 31P magnetic resonance spectroscopy to investigate skeletal muscle bioenergetics in a total of 31 patients with myotonic dystrophy. Results from resting flexor digitorum superficialis and calf muscle showed a significant elevation in the concentration ratio of inorganic phosphate to ATP and a significant reduction in the phosphorylation potential. In addition, in resting calf muscl...

متن کامل

Deprotection of Benzyl and t-Butyl Phosphate, Phosphite, and Sulfite Esters by Silica Chloride

Deprotection of phosphate, phosphate, and sulfite esters by silica chloride is described. Silica chloride is a mild, selective, and effective reagent for cleavage of benzyl and t-butyl esters of the above compounds.

متن کامل

Primary Hyperparathyroidism and Hyperthyroidism in a Patient with Myotonic Dystrophy: A Case Report and Review of the Literature

Various endocrine manifestations are commonly described in myotonic dystrophy (MD), including primary hypogonadism, diabetes mellitus, and thyroid and parathyroid dysfunction. We describe a 46-year-old woman with a family history of MD with her son. She was diagnosed with cardiac arrhythmia and required the implantation of a pacemaker. She was noted to have a bilateral cataract. She complained ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Journal of neurology, neurosurgery, and psychiatry

دوره 17 2  شماره 

صفحات  -

تاریخ انتشار 1954